Literature DB >> 24832078

Caged protein nanoparticles for drug delivery.

Nicholas M Molino1, Szu-Wen Wang2.   

Abstract

Caged protein nanoparticles possess many desirable features for drug delivery, such as ideal sizes for endocytosis, non-toxic biodegradability, and the ability to functionalize at three distinct interfaces (external, internal, and inter-subunit) using the tools of protein engineering. Researchers have harnessed these attributes by covalently and non-covalently loading therapeutic molecules through mechanisms that facilitate release within specific microenvironments. Effective delivery depends on several factors, including specific targeting, cell uptake, release kinetics, and systemic clearance. The innate ability of the immune system to recognize and respond to proteins has recently been exploited to deliver therapeutic compounds with these platforms for immunomodulation. The diversity of drugs, loading/release mechanisms, therapeutic targets, and therapeutic efficacy are discussed in this review.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24832078      PMCID: PMC4087095          DOI: 10.1016/j.copbio.2013.12.007

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN: 0958-1669            Impact factor:   9.740


  66 in total

1.  Development of a microRNA delivery system based on bacteriophage MS2 virus-like particles.

Authors:  Yang Pan; Yuan Zhang; Tingting Jia; Kuo Zhang; Jinming Li; Lunan Wang
Journal:  FEBS J       Date:  2012-02-23       Impact factor: 5.542

2.  Simultaneous gene transduction and silencing using stimuli-responsive viral/nonviral chimeric nanoparticles.

Authors:  Soo Kyung Cho; Young Jik Kwon
Journal:  Biomaterials       Date:  2012-01-24       Impact factor: 12.479

3.  Dual-surface-modified bacteriophage MS2 as an ideal scaffold for a viral capsid-based drug delivery system.

Authors:  Ernest W Kovacs; Jacob M Hooker; Dante W Romanini; Patrick G Holder; Katherine E Berry; Matthew B Francis
Journal:  Bioconjug Chem       Date:  2007-06-30       Impact factor: 4.774

4.  Dual-surface modified virus capsids for targeted delivery of photodynamic agents to cancer cells.

Authors:  Nicholas Stephanopoulos; Gary J Tong; Sonny C Hsiao; Matthew B Francis
Journal:  ACS Nano       Date:  2010-10-26       Impact factor: 15.881

5.  Incorporation of thrombin cleavage peptide into a protein cage for constructing a protease-responsive multifunctional delivery nanoplatform.

Authors:  Young Ji Kang; Dae Cheul Park; Hyun-Hee Shin; Jongnam Park; Sebyung Kang
Journal:  Biomacromolecules       Date:  2012-11-29       Impact factor: 6.988

6.  In vitro and in vivo targeted delivery of IL-10 interfering RNA by JC virus-like particles.

Authors:  Meng-Ing Chou; Yu-Fan Hsieh; Meilin Wang; Jinghua Tsai Chang; Deching Chang; Moncef Zouali; Gregory J Tsay
Journal:  J Biomed Sci       Date:  2010-06-24       Impact factor: 8.410

7.  Encapsulation of platinum anticancer drugs by apoferritin.

Authors:  Zhen Yang; Xiaoyong Wang; Huajia Diao; Junfeng Zhang; Hongyan Li; Hongzhe Sun; Zijian Guo
Journal:  Chem Commun (Camb)       Date:  2007-05-17       Impact factor: 6.222

8.  Bio-distribution, toxicity and pathology of cowpea mosaic virus nanoparticles in vivo.

Authors:  Pratik Singh; Duane Prasuhn; Robert M Yeh; Giuseppe Destito; Chris S Rae; Kent Osborn; M G Finn; Marianne Manchester
Journal:  J Control Release       Date:  2007-04-13       Impact factor: 9.776

9.  Glycan masking of Plasmodium vivax Duffy Binding Protein for probing protein binding function and vaccine development.

Authors:  Sowmya Sampath; Chris Carrico; Joel Janes; Sairam Gurumoorthy; Claire Gibson; Martin Melcher; Chetan E Chitnis; Ruobing Wang; William R Schief; Joseph D Smith
Journal:  PLoS Pathog       Date:  2013-06-13       Impact factor: 6.823

Review 10.  Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design.

Authors:  Emily M Plummer; Marianne Manchester
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2010-09-24
View more
  31 in total

Review 1.  Protein based therapeutic delivery agents: Contemporary developments and challenges.

Authors:  Liming Yin; Carlo Yuvienco; Jin Kim Montclare
Journal:  Biomaterials       Date:  2017-04-21       Impact factor: 12.479

Review 2.  Nanocaged platforms: modification, drug delivery and nanotoxicity. Opening synthetic cages to release the tiger.

Authors:  Mahdi Karimi; Parham Sahandi Zangabad; Fatemeh Mehdizadeh; Hedieh Malekzad; Alireza Ghasemi; Sajad Bahrami; Hossein Zare; Mohsen Moghoofei; Amin Hekmatmanesh; Michael R Hamblin
Journal:  Nanoscale       Date:  2017-01-26       Impact factor: 7.790

3.  Physalis Mottle Virus-Like Particles as Nanocarriers for Imaging Reagents and Drugs.

Authors:  Hema Masarapu; Bindi K Patel; Paul L Chariou; He Hu; Neetu M Gulati; Bradley L Carpenter; Reza A Ghiladi; Sourabh Shukla; Nicole F Steinmetz
Journal:  Biomacromolecules       Date:  2017-11-16       Impact factor: 6.988

Review 4.  Nanotechnology approaches for delivery of cytochrome P450 substrates in HIV treatment.

Authors:  Yuqing Gong; Pallabita Chowdhury; Prashanth K B Nagesh; Theodore J Cory; Chelsea Dezfuli; Sunitha Kodidela; Ajay Singh; Murali M Yallapu; Santosh Kumar
Journal:  Expert Opin Drug Deliv       Date:  2019-07-24       Impact factor: 6.648

Review 5.  Protein-based nanoparticles in cancer vaccine development.

Authors:  Medea Neek; Tae Il Kim; Szu-Wen Wang
Journal:  Nanomedicine       Date:  2018-10-04       Impact factor: 5.307

6.  Display of DNA on Nanoparticles for Targeting Antigen Presenting Cells.

Authors:  Nicholas M Molino; Medea Neek; Jo Anne Tucker; Edward L Nelson; Szu-Wen Wang
Journal:  ACS Biomater Sci Eng       Date:  2017-03-14

7.  Protein Nanoparticles as Multifunctional Biocatalysts and Health Assessment Sensors.

Authors:  Maryam Raeeszadeh-Sarmazdeh; Emily Hartzell; J Vincent Price; Wilfred Chen
Journal:  Curr Opin Chem Eng       Date:  2016-09-04       Impact factor: 5.163

Review 8.  Advancements in protein nanoparticle vaccine platforms to combat infectious disease.

Authors:  Nina Butkovich; Enya Li; Aaron Ramirez; Amanda M Burkhardt; Szu-Wen Wang
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2020-11-08

9.  Design and Synthesis of Piperazine-Based Compounds Conjugated to Humanized Ferritin as Delivery System of siRNA in Cancer Cells.

Authors:  Natalia Pediconi; Francesca Ghirga; Cristina Del Plato; Giovanna Peruzzi; Constantinos M Athanassopoulos; Mattia Mori; Maria Elisa Crestoni; Davide Corinti; Franco Ugozzoli; Chiara Massera; Alessandro Arcovito; Bruno Botta; Alberto Boffi; Deborah Quaglio; Paola Baiocco
Journal:  Bioconjug Chem       Date:  2021-05-12       Impact factor: 4.774

Review 10.  Chemical Conjugation Strategies for the Development of Protein-Based Subunit Nanovaccines.

Authors:  Lantian Lu; Viet Tram Duong; Ahmed O Shalash; Mariusz Skwarczynski; Istvan Toth
Journal:  Vaccines (Basel)       Date:  2021-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.